Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds

ClinicalTrials.gov ID: NCT01205061

Public ClinicalTrials.gov record NCT01205061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel® Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds

Study identification

NCT ID
NCT01205061
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Galderma R&D
Industry
Enrollment
162 participants

Conditions and interventions

Conditions

Interventions

  • Emervel Deep Lidocaine Device
  • Juvederm Ultra Plus Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 26, 2010
Primary completion
Jun 19, 2011
Completion
Jan 11, 2012
Last update posted
Oct 22, 2023

2010 – 2012

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Galderma research site Los Angeles California 90036
Galderma research site San Francisco California 94115
Galderma research site New Haven Connecticut 06511
Galderma research site Miami Beach Florida 33140
Galderma research site Snellville Georgia 30078
Galderma research site Hunt Valley Maryland 21030
Galderma research site Warren Michigan 48088
Galderma research site White Plains New York 10604
Galderma research site Charlotte North Carolina 28207
Galderma research site Nashville Tennessee 37215
Galderma research site Plano Texas 75093

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01205061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01205061 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →